Furthermore, as a key regulator of glycolysis, PFKFB3 has been regarded as a promising target for the treatment of multiple tumors, rheumatoid arthritis, pulmonary arterial hypertension, and atherosclerosis (23, 28, 53, 54). Here, PFKFB3 is linked to atherosclerosis.